MTOR and ovarian carcinoma: Concurrent activation of multiple signaling pathways, including JAK/STAT3, PI3K/AKT/mTOR, SRC, and MEK/MAPK, appears to be more common in ovarian cancer and might be the critical force that drives ovarian cancer cells to proliferate and survive [12,50].